Jedux Parenteral Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.97 Cr
- Revenue Growth 77.07%
- Profit Growth 861.45%
- Ebitda 7.43%
- Net Worth 17.92%
- Total Assets 3.00%
About Jedux Parenteral
Jedux Parenteral Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 October 2017 (Seven years and four months 21 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹44.97 Cr.
Jitendra Singh, Purnima Singh, Bhanu Singh, and One other member serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100UP2017PTC097613
- Company No.
097613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Jedux Parenteral?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Singh  | Director | 06-Oct-2017 | Current |
| Purnima Singh | Director | 30-Sep-2018 | Current |
| Bhanu Singh | Director | 06-Oct-2017 | Current |
| Pradeep Singh | Director | 06-Oct-2017 | Current |
Financial Performance of Jedux Parenteral.
Jedux Parenteral Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 77.07% increase. The company also saw a substantial improvement in profitability, with a 861.45% increase in profit. The company's net worth Soared by an impressive increase of 17.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jedux Parenteral?
In 2021, Jedux Parenteral had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Jagannath Vijay Singh FoundationBhanu Singh and Pradeep Singh are mutual person
- Greenville Infratech Private Limited
Pradeep Singh is a mutual person
- Jagannath & Vimla Singh Foundation
Pradeep Singh is a mutual person
Charges (Loans)
₹44.97 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 44.97 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2018 | State Bank Of India | ₹2.70 M | Open |
| 05 Nov 2018 | State Bank Of India | ₹2.55 M | Open |
| 11 Oct 2018 | State Bank Of India | ₹2.70 M | Open |
| 19 Mar 2018 | State Bank Of India | ₹44.17 Cr | Open |
How Many Employees Work at Jedux Parenteral?
Unlock and access historical data on people associated with Jedux Parenteral, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jedux Parenteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jedux Parenteral's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.